ECSU researchers advance biomedical science with artificial intelligence

Elizabeth City State University is leveraging artificial intelligence and machine learning to transform prostate cancer research and address health disparities.

Elizabeth City State University researchers have launched a groundbreaking biomedical science initiative, utilizing artificial intelligence and machine learning to tackle persistent health disparities. Led by Kuldeep Rawat, principal investigator and Thorpe Endowed Professor, along with co-principal investigator and biology professor Hirendranath Banerjee, the interdisciplinary team has secured a significant grant from the National Institutes of Health through a partnership with Vanderbilt University. Their primary mission is to deploy advanced computational techniques to analyze genomics and transcriptomic data from prostate cancer patients, with a focus on delivering personalized diagnostics and treatments.

The research is funded under the AIM-AHEAD artificial intelligence/machine learning in Biomedical Research and Clinical Practice that Embodies Ethics and Equity (ABD-EE) program, an initiative designed to champion the development of responsible, equitable, data-driven solutions in health care. By emphasizing the creation of effective diagnostic and prognostic biomarkers, the ECSU project seeks not only to advance scientific understanding but also to address the particular risk prostate cancer poses to African American men, a group historically underserved in mainstream medical research and treatment innovations.

Beyond the immediate scientific goals, this project is seen as a transformative step for ECSU. It strengthens the university’s growing research portfolio in biomedical innovation and data science while providing practical training opportunities for post-doctoral researchers, graduate, and undergraduate students. The initiative aims to elevate ECSU’s capacity to contribute to high-impact research, offering both new analytical tools and a more inclusive approach to cancer care. Ultimately, the researchers hope their advances will lead to more accurate and equitable outcomes for communities that have long been marginalized in health care progress, signaling a shift towards technology-driven hope and empowerment.

72

Impact Score

Congress weighs Artificial Intelligence transparency rules

Bipartisan lawmakers are pushing a federal transparency standard for the largest Artificial Intelligence models as Congress works on a broader national framework. The proposal aims to increase public trust while avoiding stricter state-by-state requirements and heavier regulation.

Report finds California creative job losses are not driven by Artificial Intelligence

New research from Otis College of Art and Design finds California’s recent creative industry job losses stem from cost pressures and structural shifts, not direct worker displacement by generative Artificial Intelligence. The technology is changing workflows and expectations, but it is largely replacing tasks rather than entire jobs.

U.S. senators propose broader chip tool export ban for Chinese firms

A bipartisan proposal in the U.S. Senate would shift semiconductor equipment controls from specific fabs to targeted Chinese companies and their affiliates. The measure is aimed at cutting off access to advanced lithography and other wafer fabrication tools for firms such as Huawei, SMIC, YMTC, CXMT, and Hua Hong.

Trump executive order targets state Artificial Intelligence laws

Executive Order 14365 lays out a federal strategy to discourage, challenge, and potentially preempt state Artificial Intelligence laws viewed as burdensome. Employers are advised to keep complying with current state and local rules while preparing for regulatory uncertainty in 2026.

Who decides how America uses Artificial Intelligence in war

Stanford experts are divided over how the United States should govern Artificial Intelligence in defense, surveillance, and warfare. Their views converge on one point: decisions with such high stakes cannot be left to companies alone.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.